EA033519B1 - Фармацевтическая композиция с содержанием селенита или содержащие селенит соединения для лечения дисплазий или карцином шейки матки - Google Patents

Фармацевтическая композиция с содержанием селенита или содержащие селенит соединения для лечения дисплазий или карцином шейки матки

Info

Publication number
EA033519B1
EA033519B1 EA201691236A EA201691236A EA033519B1 EA 033519 B1 EA033519 B1 EA 033519B1 EA 201691236 A EA201691236 A EA 201691236A EA 201691236 A EA201691236 A EA 201691236A EA 033519 B1 EA033519 B1 EA 033519B1
Authority
EA
Eurasian Patent Office
Prior art keywords
selenite
carcinomas
pharmaceutical composition
treating cervical
acid
Prior art date
Application number
EA201691236A
Other languages
English (en)
Other versions
EA201691236A1 (ru
Inventor
Norbert Fuchs
Original Assignee
Selo Medical Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selo Medical Gmbh filed Critical Selo Medical Gmbh
Publication of EA201691236A1 publication Critical patent/EA201691236A1/ru
Publication of EA033519B1 publication Critical patent/EA033519B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

В изобретении описаны композиции, содержащие селенитовые соединения и фармацевтически приемлемые кислоты, выбранные из уксусной, яблочной, угольной, серной, азотной, соляной кислот, плодовых кислот или их смесей, и предназначенные для применения при лечении воспалений, дисплазии и/или карцином шейки матки.
EA201691236A 2011-02-16 2012-02-16 Фармацевтическая композиция с содержанием селенита или содержащие селенит соединения для лечения дисплазий или карцином шейки матки EA033519B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ATA201/2011A AT511159A1 (de) 2011-02-16 2011-02-16 Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen

Publications (2)

Publication Number Publication Date
EA201691236A1 EA201691236A1 (ru) 2016-10-31
EA033519B1 true EA033519B1 (ru) 2019-10-31

Family

ID=45807993

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201300910A EA025419B1 (ru) 2011-02-16 2012-02-16 Фармацевтическая композиция, содержащая селенит натрия и лимонную кислоту, для лечения дисплазий или карцином шейки матки
EA201691236A EA033519B1 (ru) 2011-02-16 2012-02-16 Фармацевтическая композиция с содержанием селенита или содержащие селенит соединения для лечения дисплазий или карцином шейки матки

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201300910A EA025419B1 (ru) 2011-02-16 2012-02-16 Фармацевтическая композиция, содержащая селенит натрия и лимонную кислоту, для лечения дисплазий или карцином шейки матки

Country Status (28)

Country Link
US (3) US10201566B2 (ru)
EP (1) EP2675432B1 (ru)
JP (1) JP5986110B2 (ru)
CN (2) CN103379899A (ru)
AR (1) AR085265A1 (ru)
AT (1) AT511159A1 (ru)
AU (1) AU2012219005B2 (ru)
BR (1) BR112013020702B1 (ru)
CA (1) CA2826999C (ru)
CL (1) CL2013002353A1 (ru)
CY (1) CY1117768T1 (ru)
EA (2) EA025419B1 (ru)
ES (1) ES2577150T3 (ru)
GE (1) GEP201606590B (ru)
HK (1) HK1243360A1 (ru)
HR (1) HRP20160891T1 (ru)
HU (1) HUE029811T2 (ru)
IL (1) IL227981A (ru)
ME (1) ME02422B (ru)
MX (1) MX342098B (ru)
PL (1) PL2675432T3 (ru)
PT (1) PT2675432T (ru)
RS (1) RS54952B1 (ru)
SI (1) SI2675432T1 (ru)
SM (1) SMT201600233B (ru)
TW (1) TWI538678B (ru)
UA (1) UA112767C2 (ru)
WO (1) WO2012109685A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2804244C1 (ru) * 2022-11-19 2023-09-26 Общество с ограниченной ответственностью "ФорД" Средство для лечения рака шейки матки

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012222956A1 (de) * 2012-12-12 2014-06-12 Beiersdorf Ag Kosmetische Zubereitungen mit Fließgrenze
EP3616693A1 (en) * 2018-08-28 2020-03-04 Selo Medical GmbH Therapy of high-risk human papillomavirus infections
WO2021041825A1 (en) * 2019-08-30 2021-03-04 Musc Foundation For Research Development Sphingolipid-based selenium compounds, methods for their preparation, and pharmaceutical uses thereof, including as antitumor agents
EP3875083A1 (en) * 2020-03-03 2021-09-08 Selo Medical GmbH Composition for use in a treatment of cervical cell abnormalities comprising selenite compound and acid
WO2021263206A1 (en) * 2020-06-26 2021-12-30 Prothione, Llc Compositions and methods for the treatment of covid-19

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003047604A1 (de) * 2001-12-04 2003-06-12 Vis-Vitalis Lizenz-Und Handels Ag Verwendung von selenithältigen verbindungen zur topischen oder bukkalen anwendung

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1112164A (en) 1977-08-02 1981-11-10 Joseph R. Levitt Therapeutic selenium compositions and the use thereof
US4512977A (en) 1979-10-18 1985-04-23 Lundy Research Laboratories, Inc. Therapeutic selenium compositions and the use thereof
IT1161213B (it) 1983-03-08 1987-03-18 Fcn Srl Composizioni farmaceutiche ad attivita' antineoplastica
US4762726A (en) 1983-12-30 1988-08-09 Kraft, Inc. Shelf stable acid food dressings containing fibrous protein complexes
US4668515A (en) 1984-03-06 1987-05-26 Paul Bankit Method and compositions for sodium selenite administration
US5389677B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
US5153230A (en) 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
US5182104A (en) 1991-07-16 1993-01-26 Stanley Marcus Topical virucidal composition for treatment of mucocutaneous tissue
CA2131177C (en) 1992-03-11 1997-08-05 Hing Cheung Tse Psyllium drink mix compositions containing granulated base
US5425944A (en) 1992-10-27 1995-06-20 Harich; Jakob Antimicrobial grapefruit extract
US5536497A (en) 1992-12-21 1996-07-16 The Research Foundation Of State University Of New York Fimbrial polypeptides useful in the prevention of periodontitis
DE4320694C2 (de) 1993-06-22 1999-11-11 Biosyn Arzneimittel Gmbh Vewendung von Selenverbindungen zur äußeren Anwendung bei Warzen
US5484612A (en) 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
DE4335441A1 (de) 1993-10-18 1995-04-20 Hans Dipl Chem Heide Mittel zur Gesundheitsvorsorge im Herz- Kreislaufsystem beim Menschen
US5512200A (en) 1994-04-18 1996-04-30 Thomas G. Bongard Low pH Acidic Compositions
DE4413839C1 (de) 1994-04-21 1995-10-19 Fritz Koch Pharma Gmbh Dr Med Kombinationspräparat
DE69629874T2 (de) 1995-06-07 2004-07-08 Life Science Labs, Inc., Minneapolis Selen enthaltende Zusammensetzung zur Reduzierung der Krebshäufigkeit und zur Verlängerung des Lebensalters
GB2323030A (en) 1997-03-12 1998-09-16 Essential Nutrition Ltd Dietary supplements for immunocompromised patients
US5999844A (en) * 1997-04-23 1999-12-07 Accumed International, Inc. Method and apparatus for imaging and sampling diseased tissue using autofluorescence
US6069152A (en) 1997-10-07 2000-05-30 Eli Lilly And Company 5-HT4 agonists and antagonists
GB9722361D0 (en) 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders
IT1297080B1 (it) 1997-11-26 1999-08-03 Andrea Carnevali Composizione per il trattamento di ustioni, eritemi solari, abrasioni, piaghe e irritazioni cutanee
US6228347B1 (en) 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
FR2779720B1 (fr) 1998-06-12 2002-08-16 Galderma Rech Dermatologique Nouveaux composes diarylselenures et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
US6120758A (en) 1998-07-16 2000-09-19 Shaklee Corporation Preservative system for topically applied products
FR2782642B1 (fr) 1998-08-31 2001-12-07 Xavier Forceville Utilisation du selenium pour le traitement de patients atteints d'un syndrome de reponse inflammatoire systemique (sirs), et composition pour la mise en oeuvre du traitement
US6114348A (en) 1999-03-10 2000-09-05 Weber; Paul J. Method of treating warts using tazarotene
JP2003532608A (ja) 2000-05-10 2003-11-05 オーコファーム フォーシュンクス−ウント エントウィックルングス−ゲゼルシャフト ミット ベシュレンクテル ハフトング 二酸化ケイ素の表面積を低減する方法
AT412758B (de) 2000-06-05 2005-07-25 Vis Vitalis Lizenz & Handels Verwendung einer selenithältigen lösung zur behandlung viraler erkrankungen
AT412448B (de) 2001-02-13 2005-03-25 Vis Vitalis Lizenz & Handels Verwendung von selenhältigen präparaten

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003047604A1 (de) * 2001-12-04 2003-06-12 Vis-Vitalis Lizenz-Und Handels Ag Verwendung von selenithältigen verbindungen zur topischen oder bukkalen anwendung

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LIPING FU, QIONG LIU, LIMING SHEN, YONG WANG: "Proteomic study on sodium selenite-induced apoptosis of human cervical cancer HeLa cells", JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, URBAN & FISCHER, vol. 25, no. 3, 1 July 2011 (2011-07-01), pages 130 - 137, XP055023165, ISSN: 0946672X, DOI: 10.1016/j.jtemb.2011.06.001 *
RUDOLF E. ET AL.: "Selenium activates p53 and p38 pathways and induces caspase-independent cell death in cervical cancer cells", CELL BIOLOGY AND TOXICOLOGY, KLUWER ACADEMIC PUBLISHERS, DO, vol. 24, no. 2, 3 July 2007 (2007-07-03), pages 123-141, XP019570904, ISSN: 1573-6822, page 135, right-hand column, page 137, left-hand column, page 140r, last paragraph *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2804244C1 (ru) * 2022-11-19 2023-09-26 Общество с ограниченной ответственностью "ФорД" Средство для лечения рака шейки матки

Also Published As

Publication number Publication date
BR112013020702B1 (pt) 2021-09-08
MX342098B (es) 2016-09-13
BR112013020702A2 (pt) 2016-10-18
CN107582563B (zh) 2021-03-19
EP2675432A1 (de) 2013-12-25
ES2577150T3 (es) 2016-07-13
CL2013002353A1 (es) 2014-06-27
JP5986110B2 (ja) 2016-09-06
JP2014505708A (ja) 2014-03-06
ME02422B (me) 2016-09-20
RS54952B1 (sr) 2016-11-30
HUE029811T2 (hu) 2017-03-28
CN103379899A (zh) 2013-10-30
US20130323328A1 (en) 2013-12-05
CY1117768T1 (el) 2017-05-17
UA112767C2 (uk) 2016-10-25
US20190125787A1 (en) 2019-05-02
IL227981A (en) 2017-03-30
AU2012219005B2 (en) 2016-08-25
SMT201600233B (it) 2016-08-31
EA201691236A1 (ru) 2016-10-31
CN107582563A (zh) 2018-01-16
HRP20160891T1 (hr) 2016-09-23
HK1243360A1 (zh) 2018-07-13
MX2013009459A (es) 2013-12-12
AU2012219005A1 (en) 2013-09-19
PT2675432T (pt) 2016-07-26
CA2826999C (en) 2019-01-15
AR085265A1 (es) 2013-09-18
CA2826999A1 (en) 2012-08-23
PL2675432T3 (pl) 2016-10-31
EA201300910A1 (ru) 2014-02-28
IL227981A0 (en) 2013-09-30
US10201566B2 (en) 2019-02-12
GEP201606590B (en) 2017-01-10
EP2675432B1 (de) 2016-04-20
US10543228B2 (en) 2020-01-28
TW201309308A (zh) 2013-03-01
SI2675432T1 (sl) 2016-08-31
US20200206262A1 (en) 2020-07-02
TWI538678B (zh) 2016-06-21
EA025419B1 (ru) 2016-12-30
AT511159A1 (de) 2012-09-15
WO2012109685A1 (de) 2012-08-23

Similar Documents

Publication Publication Date Title
IN2015DN01156A (ru)
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
IL232267A (en) Derivatives of (4-phenylimidazole-2-ram) ethylamine, pharmaceuticals containing them used to treat them in diseases where sodium channel inhibition nav 1.8 is effective
MY147994A (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
WO2013072932A3 (en) Oral care compositions
WO2011082273A3 (en) Substituted pyrrolo-aminopyrimidine compounds
MX2015007796A (es) Derivados de cloro-pirazin carboxamida con actividad bloqueadora sobre los canales de sodio epiteliales.
WO2010139979A3 (en) Processes for preparing crystalline forms of dasatinib
WO2011082270A3 (en) Substituted imidazopyridinyl-aminopyridine compounds
EP2431366A4 (en) NEW CONJUGATED CHLORINE E6 FOLIC ACID COMPOUND, METHOD OF MANUFACTURING THEREOF AND PHARMACEUTICAL COMPOUNDS THEREOF FOR THE TREATMENT OF CANCER
WO2011082267A3 (en) Substituted triazolo-pyrazine compounds
UA98804C2 (ru) Катехоламиновые производные и фармацевтическая композиция на их основе
NZ723971A (en) Methods and compositions for treating ewings sarcoma family of tumors
WO2011150190A3 (en) Hcv inhibitor compounds and methods of use thereof
EA033519B1 (ru) Фармацевтическая композиция с содержанием селенита или содержащие селенит соединения для лечения дисплазий или карцином шейки матки
WO2011082268A3 (en) Substituted naphthalenyl-pyrimidine compounds
IN2012DN01292A (ru)
WO2012064396A3 (en) Novel ezrin inhibitors and methods of making and using
PT2247573E (pt) Sais carbónicos e de ácido sulfúrico de ésteres de 3-(2,2,2- trimetil-hidrazínio)propionato e sua utilização para a preparação de di-hidrato de 3-(2,2,2-trimetilhidrazínio) propionato
WO2012061342A3 (en) Substituted benzo-imidazo-pyrido-diazepine compounds
MX348147B (es) Biarilsulfonamidas utiles en el tratamiento de la inflamacion y cancer.
WO2012019428A8 (zh) 二苯甲醇类衍生物、其制备方法及其在医药上的应用
WO2012004588A3 (en) Therapeutic agents 976
MX2010010485A (es) Compuesto calcimimetico para su uso en el tratamiento de lesiones epiteliales.
WO2009142968A3 (en) Valproic acid salts